Recent Quotes

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-05
REV		(EXPECTED)2021-08-05

Q1 2021		Est.		Actual		Surprise
EPS		0.180		0.200		0.0200
REV		515.340M		493.105M		-22.235M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
AMRX	Amneal Pharmaceuticals	5.76	0.06	1.05%		856.6M

Amneal Pharmaceuticals Frequently Asked Questions

How do I buy Amneal Pharmaceuticals (AMRX) stock?

You can purchase shares of Amneal Pharmaceuticals (NYSE: AMRX) through any online brokerage.

View our list of the best stock brokerages.

Who are Amneal Pharmaceuticals's (AMRX) competitors?

Other companies in Amneal Pharmaceuticals’s space includes: Theravance Biopharma (NASDAQ:TBPH), Aerie Pharmaceuticals (NASDAQ:AERI), Phibro Animal Health (NASDAQ:PAHC), Tarsus Pharmaceuticals (NASDAQ:TARS) and Provention Bio (NASDAQ:PRVB).

What is the target price for Amneal Pharmaceuticals (AMRX) stock?

The latest price target for Amneal Pharmaceuticals (NYSE: AMRX) was reported by Goldman Sachs on March 8, 2021. The analyst firm set a price target for 6.50 expecting AMRX to rise to within 12 months (a possible 12.85% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for Amneal Pharmaceuticals (AMRX)?

The stock price for Amneal Pharmaceuticals (NYSE: AMRX) is $5.76 last updated Wed Jun 16 2021 19:59:44 GMT+0000 (Coordinated Universal Time).

Does Amneal Pharmaceuticals (AMRX) pay a dividend?

There are no upcoming dividends for Amneal Pharmaceuticals.

When is Amneal Pharmaceuticals (NYSE:AMRX) reporting earnings?

Amneal Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 5, 2021.

Is Amneal Pharmaceuticals (AMRX) going to split?

There is no upcoming split for Amneal Pharmaceuticals.

What sector and industry does Amneal Pharmaceuticals (AMRX) operate in?

Amneal Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NYSE.